Detalhe da pesquisa
1.
Final analyses of the prospective controlled trial on the efficacy of uracil and tegafur/leucovorin as an adjuvant treatment for stage II colon cancer with risk factors for recurrence using propensity score-based methods (JFMC46-1201).
Int J Clin Oncol
; 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38833114
2.
Prospective observational study of the efficacy of oral uracil and tegafur plus leucovorin for stage II colon cancer with risk factors for recurrence using propensity score matching (JFMC46-1201).
BMC Cancer
; 22(1): 170, 2022 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35168560
3.
Impact of chronological age on efficacy and safety of fluoropyrimidine plus bevacizumab in older non-frail patients with metastatic colorectal cancer: a combined analysis of individual data from two phase II studies of patients aged >75 years.
Jpn J Clin Oncol
; 52(7): 725-734, 2022 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35470391
4.
Nanoparticle albumin-bound paclitaxel and ramucirumab versus paclitaxel and ramucirumab as second-line chemotherapy for unresectable advanced or recurrent gastric cancer: a multicenter, propensity score-matched analysis (CROSS SELL study).
Int J Clin Oncol
; 27(4): 684-694, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35089459
5.
Efficacy and Safety of Three-dimensional Conformal Radiotherapy for Macroscopic Vascular Invasion of Hepatocellular Carcinoma.
Acta Med Okayama
; 76(6): 679-688, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36549770
6.
Handling of Germline Findings in Clinical Comprehensive Cancer Genomic Profiling.
Acta Med Okayama
; 76(6): 673-678, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36549769
7.
Time-dependent discrepancies between physician-assessed and patient-reported oxaliplatin-induced peripheral neuropathy in patients with metastatic colorectal cancer who received mFOLFOX6 plus bevacizumab: a post hoc analysis (WJOG4407GSS2).
Support Care Cancer
; 29(7): 3715-3723, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33200233
8.
Retrospective analysis for the efficacy and safety of nivolumab in advanced gastric cancer patients according to ascites burden.
Int J Clin Oncol
; 26(2): 370-377, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33090284
9.
S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 21(8): 1045-1056, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32682457
10.
Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel administered to patients with severe peritoneal metastases of gastric cancer (JCOG1108/WJOG7312G).
Gastric Cancer
; 23(4): 677-688, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32036492
11.
A robust culture method for maintaining tumorigenic cancer stem cells in the hepatocellular carcinoma cell line Li-7.
Cancer Sci
; 110(5): 1644-1652, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30784169
12.
Augmented antitumor activity of 5-fluorouracil by double knockdown of MDM4 and MDM2 in colon and gastric cancer cells.
Cancer Sci
; 110(2): 639-649, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30488540
13.
Sex differences in the safety of S-1 plus oxaliplatin and S-1 plus cisplatin for patients with metastatic gastric cancer.
Cancer Sci
; 110(9): 2875-2883, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31254422
14.
Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial).
Br J Cancer
; 121(3): 222-229, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31285591
15.
aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin- or Irinotecan-Based Chemotherapy in Patients with Metastatic Colorectal Cancer.
Oncologist
; 24(3): 327-337, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30425180
16.
Early tumor shrinkage and depth of response in patients with advanced gastric cancer: a retrospective analysis of a randomized phase III study of first-line S-1 plus oxaliplatin vs. S-1 plus cisplatin.
Gastric Cancer
; 22(1): 138-146, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29948386
17.
Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER).
Int J Clin Oncol
; 24(10): 1214-1222, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31089842
18.
Anal canal adenocarcinoma with neuroendocrine features accompanying secondary extramammary Paget disease, successfully treated with modified FOLFOX6: a case report.
BMC Cancer
; 18(1): 1142, 2018 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30458812
19.
Newly developed endoscopic detachable snare ligation therapy for colonic diverticular hemorrhage: a multicenter phase II trial (with videos).
Gastrointest Endosc
; 88(2): 370-377, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29679691
20.
Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G).
Gastric Cancer
; 21(1): 84-95, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28497176